JP2018504892A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018504892A5 JP2018504892A5 JP2017531209A JP2017531209A JP2018504892A5 JP 2018504892 A5 JP2018504892 A5 JP 2018504892A5 JP 2017531209 A JP2017531209 A JP 2017531209A JP 2017531209 A JP2017531209 A JP 2017531209A JP 2018504892 A5 JP2018504892 A5 JP 2018504892A5
- Authority
- JP
- Japan
- Prior art keywords
- classifier score
- breast cancer
- subject
- luminal
- basal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462091195P | 2014-12-12 | 2014-12-12 | |
| US62/091,195 | 2014-12-12 | ||
| US201562142504P | 2015-04-03 | 2015-04-03 | |
| US62/142,504 | 2015-04-03 | ||
| US201562167110P | 2015-05-27 | 2015-05-27 | |
| US62/167,110 | 2015-05-27 | ||
| PCT/US2015/064500 WO2016094408A1 (en) | 2014-12-12 | 2015-12-08 | Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018504892A JP2018504892A (ja) | 2018-02-22 |
| JP2018504892A5 true JP2018504892A5 (enExample) | 2019-01-24 |
| JP6735277B2 JP6735277B2 (ja) | 2020-08-05 |
Family
ID=55273509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017531209A Expired - Fee Related JP6735277B2 (ja) | 2014-12-12 | 2015-12-08 | 乳癌療法剤に対する反応を予測するための方法および乳癌の処置の方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US10196693B2 (enExample) |
| EP (2) | EP3604556A1 (enExample) |
| JP (1) | JP6735277B2 (enExample) |
| KR (1) | KR20170095306A (enExample) |
| CN (1) | CN107109488A (enExample) |
| AU (1) | AU2015360767A1 (enExample) |
| BR (1) | BR112017012142A2 (enExample) |
| CA (1) | CA2970469A1 (enExample) |
| ES (1) | ES2748005T3 (enExample) |
| IL (1) | IL252587A0 (enExample) |
| MX (1) | MX2017007707A (enExample) |
| RU (1) | RU2017120330A (enExample) |
| SG (1) | SG11201704425TA (enExample) |
| WO (1) | WO2016094408A1 (enExample) |
| ZA (1) | ZA201703904B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9517229B2 (en) | 2011-07-29 | 2016-12-13 | Medivation Prostate Therapeutics, Inc. | Treatment of breast cancer |
| US20140243211A1 (en) | 2013-02-28 | 2014-08-28 | Indiana University Research & Technology Corporation | Blood biomarkers for suicidality |
| BR112017012142A2 (pt) | 2014-12-12 | 2018-01-02 | Medivation Prostate Therapeutics Inc | método para predição da resposta a agentes terapêuticos para o câncer de mama e método de tratamento de câncer de mama |
| AU2016274988A1 (en) | 2015-06-12 | 2017-12-21 | Indiana University Research & Technology Corporation | Predicting suicidality using a combined genomic and clinical risk assessment |
| KR101966493B1 (ko) * | 2016-06-27 | 2019-04-05 | 국립암센터 | 삼중음성유방암 예후 예측용 바이오마커 |
| KR101896558B1 (ko) * | 2016-11-21 | 2018-09-07 | 주식회사 젠큐릭스 | 유방암 환자의 예후 예측 방법 |
| WO2018198927A1 (ja) * | 2017-04-26 | 2018-11-01 | 日本電信電話株式会社 | Ｎ×ｎ光スイッチ |
| CA3105451A1 (en) | 2017-05-12 | 2018-11-15 | Indiana University Research And Technology Corporation | Precision medicine for treating and preventing suicidality |
| RU2648523C1 (ru) * | 2017-05-22 | 2018-03-26 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр" Российской академии наук ("Томский НИМЦ") | Способ прогнозирования исхода заболевания у больных люминальным в и трижды негативным раком молочной железы у пациенток, не получавших в неоадъювантном режиме химио- или гормонотерапию |
| AU2019268481B2 (en) * | 2018-05-14 | 2025-04-03 | Hinova Pharmaceuticals Inc. | HC-1119 formulation, preparation method and use thereof |
| WO2020001473A1 (zh) * | 2018-06-28 | 2020-01-02 | 复旦大学 | 小核仁核糖核酸snord33作为生物标记物用于制备检测试剂盒中的用途 |
| CN109735625A (zh) * | 2019-03-18 | 2019-05-10 | 马榕 | 乳头溢液在检测肿瘤相关基因中的应用 |
| CN114334000B (zh) * | 2021-12-28 | 2025-07-25 | 上海中医药大学 | 基于转录组图谱的组合药物生成方法、系统及存储介质 |
| US20260043086A1 (en) * | 2022-08-06 | 2026-02-12 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Predictive biomarker in avastin in colon cancer |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| EP0880598A4 (en) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM |
| JP2001521753A (ja) | 1997-10-31 | 2001-11-13 | アフィメトリックス インコーポレイテッド | 成人臓器及び胎児臓器中の発現プロフィール |
| US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
| US6937713B1 (en) | 1999-12-30 | 2005-08-30 | At&T Corp. | IP call forward profile |
| US7504222B2 (en) | 2001-10-31 | 2009-03-17 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| US20070192880A1 (en) | 2003-10-03 | 2007-08-16 | University Of Rochester | Horming response element binding transregulators |
| US20070059720A9 (en) | 2004-12-06 | 2007-03-15 | Suzanne Fuqua | RNA expression profile predicting response to tamoxifen in breast cancer patients |
| US7709517B2 (en) | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
| NZ564223A (en) | 2005-05-13 | 2011-03-31 | Univ California | Diarylhydantoin compounds for treating hormone refractory prostate cancer |
| CA2630974A1 (en) | 2005-11-23 | 2007-05-31 | University Of Utah Research Foundation | Methods and compositions involving intrinsic genes |
| BRPI0709771B1 (pt) | 2006-03-27 | 2022-01-25 | The Regents Of The University Of California | Composto e composição farmacêutica |
| NZ596260A (en) | 2006-03-29 | 2013-05-31 | Univ California | Diarylthiohydantoin compounds |
| TWI469971B (zh) | 2007-10-26 | 2015-01-21 | Univ California | 二芳基乙內醯脲類化合物 |
| WO2009064738A2 (en) * | 2007-11-12 | 2009-05-22 | Bipar Sciences, Inc. | Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents |
| US8450290B2 (en) | 2007-11-26 | 2013-05-28 | Enzon Pharmaceuticals, Inc. | Methods for treating androgen receptor dependent disorders including cancers |
| WO2009114534A1 (en) | 2008-03-14 | 2009-09-17 | The Regents Of The University Of California | Multi-gene classifiers and prognostic indicators for cancers |
| SI2297359T1 (sl) | 2008-05-30 | 2014-05-30 | The University Of North Carolina At Chapel Hill | Profili genskega izraĹľanja za napovedovanje izida raka dojke |
| JP2012518661A (ja) | 2009-02-24 | 2012-08-16 | メディベイション プロステイト セラピューティクス， インコーポレイテッド | 特定のジアリールヒダントインおよびジアリールチオヒダントイン化合物 |
| EP2416657A4 (en) | 2009-04-09 | 2012-09-05 | Medivation Prostate Therapeutics Inc | COMPOUNDS COMPRISING SUBSTITUTED DI-ARYLHYDANTOIDS AND DI-ARYLTHIOHYDANTOINES AND METHODS OF USE THEREOF |
| EP2425015B1 (en) | 2009-04-29 | 2018-01-10 | Ralph Wirtz | A method to assess prognosis and to predict therapeutic success in cancer by determining hormone receptor expression levels |
| US8507195B2 (en) | 2009-08-20 | 2013-08-13 | The Regents Of The University Of Colorado | MiRNAs dysregulated in triple-negative breast cancer |
| EP2473619A4 (en) | 2009-09-03 | 2013-03-27 | Scripps Research Inst | METHOD FOR CATEGORIZING CIRCULATING TUMOR CELLS |
| WO2011044327A1 (en) | 2009-10-07 | 2011-04-14 | Medivation Prostate Therapeutics, Inc. | Substituted phenylcarbamoyl alkylamino arene compounds and n,n'-bis-arylurea compounds |
| JP5971769B2 (ja) | 2011-03-15 | 2016-08-17 | ザ ユニバーシティー オブ ノースカロライナ アット チャペル ヒル | アントラサイクリン療法を用いて乳癌を処置する方法 |
| US8781912B2 (en) | 2011-03-15 | 2014-07-15 | Opera Solutions, Llc | Computer-based method and computer program product for setting floor prices for items sold at auction |
| US9517229B2 (en) | 2011-07-29 | 2016-12-13 | Medivation Prostate Therapeutics, Inc. | Treatment of breast cancer |
| WO2013082440A2 (en) | 2011-11-30 | 2013-06-06 | The University Of North Carolina At Chapel Hill | Methods of treating breast cancer with taxane therapy |
| WO2014031164A1 (en) | 2012-08-23 | 2014-02-27 | The Regents Of The University Of Colorado, A Body Corporate | Method for determining breast cancer treatment |
| US9175291B2 (en) * | 2012-10-11 | 2015-11-03 | Isis Pharmaceuticals Inc. | Modulation of androgen receptor expression |
| WO2014075067A1 (en) | 2012-11-12 | 2014-05-15 | Nanostring Technologies, Inc. | Methods to predict breast cancer outcome |
| US10679730B2 (en) * | 2013-05-28 | 2020-06-09 | The University Of Chicago | Prognostic and predictive breast cancer signature |
| BR112017012142A2 (pt) | 2014-12-12 | 2018-01-02 | Medivation Prostate Therapeutics Inc | método para predição da resposta a agentes terapêuticos para o câncer de mama e método de tratamento de câncer de mama |
-
2015
- 2015-12-08 BR BR112017012142A patent/BR112017012142A2/pt not_active IP Right Cessation
- 2015-12-08 WO PCT/US2015/064500 patent/WO2016094408A1/en not_active Ceased
- 2015-12-08 SG SG11201704425TA patent/SG11201704425TA/en unknown
- 2015-12-08 JP JP2017531209A patent/JP6735277B2/ja not_active Expired - Fee Related
- 2015-12-08 EP EP19192143.6A patent/EP3604556A1/en not_active Withdrawn
- 2015-12-08 AU AU2015360767A patent/AU2015360767A1/en not_active Abandoned
- 2015-12-08 KR KR1020177019159A patent/KR20170095306A/ko not_active Withdrawn
- 2015-12-08 MX MX2017007707A patent/MX2017007707A/es unknown
- 2015-12-08 ES ES15831013T patent/ES2748005T3/es active Active
- 2015-12-08 RU RU2017120330A patent/RU2017120330A/ru not_active Application Discontinuation
- 2015-12-08 EP EP15831013.6A patent/EP3230471B1/en not_active Not-in-force
- 2015-12-08 US US14/962,864 patent/US10196693B2/en active Active
- 2015-12-08 CA CA2970469A patent/CA2970469A1/en active Pending
- 2015-12-08 CN CN201580068041.7A patent/CN107109488A/zh active Pending
-
2017
- 2017-05-30 IL IL252587A patent/IL252587A0/en unknown
- 2017-06-07 ZA ZA2017/03904A patent/ZA201703904B/en unknown
-
2018
- 2018-12-10 US US16/215,340 patent/US11186876B2/en active Active
-
2021
- 2021-11-10 US US17/523,235 patent/US11952634B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2017120330A (ru) | Способ прогнозирования ответа на терапевтические агенты для лечения рака молочной железы и способ лечения рака молочной железы | |
| JP7013388B2 (ja) | Ｈｄａｃ阻害剤とｐｄ－ｌ１阻害剤との組み合わせ療法 | |
| KR20160006668A (ko) | 브루톤 티로신 키나제 억제제와 cyp3a4 억제제의 배합물 | |
| JP2021502345A (ja) | 抗がん剤 | |
| WO2012167028A2 (en) | Compositions and methods for treating cancer and diseases and conditions responsive to cell growth inhibition | |
| Cheong et al. | Enhanced autophagy in cytarabine arabinoside-resistant U937 leukemia cells and its potential as a target for overcoming resistance | |
| CN107405316A (zh) | 用于治疗原发性激素耐受性子宫内膜癌和乳腺癌的方法 | |
| Lu et al. | Cancer metastasis, a clinical dilemma for therapeutics | |
| CN108779111B (zh) | 结合脱氧胞苷激酶的化合物 | |
| JP2018513155A (ja) | セリバンツマブを用いた併用療法 | |
| Saadh et al. | Long non-coding RNAs: controversial roles in drug resistance of solid tumors mediated by autophagy | |
| Lan et al. | Beyond boundaries: unraveling innovative approaches to combat bone-metastatic cancers | |
| CN112218627A (zh) | 前药及其在医学上的应用 | |
| Tian et al. | 1014P Resistance landscape to almonertinib in EGFR-mutated NSCLC | |
| WO2018144597A1 (en) | Methods of sensitizing cancer cells to immune cell killing | |
| Wasi | Skeletal Effects of Combined Yoda1 and Tibial Loading in Aged Mice Bearing Metastatic Breast Cancer and Undergoing Chemotherapy | |
| O'Byrne et al. | 1013P Utilizing a combined biomarker and therapeutic strategy to reverse TKI resistance in EGFR mutant non-small cell lung cancer | |
| RU2706029C1 (ru) | Способ лечения люминального подтипа рака молочной железы | |
| JP2020500543A5 (enExample) | ||
| Mitra et al. | 121P Calcite-driven cytotoxicity in glioblastoma cells: A promising therapeutic approach | |
| Ge et al. | Emodin sensitizes ovarian cancer cells to carboplatin through suppression of mitochondrial respiration | |
| Ahmed et al. | 128P Network medicine approach identifies small molecule drugs as immune checkpoint inhibitors repurposable for rectal cancer | |
| Li et al. | Effect of DDX46 targeted suppression on the proliferation and apoptosis of ovarian cancer cell line SK-OV-3 | |
| Kang | Estimation of efficacy and safety of a Cremophor-free, polymeric micelle formulation of paclitaxel, in recurrent or metastatic breast cancer patients | |
| Ansari et al. | CXCR4 antagonist mediated targeting of cancer cells using nanoparticles |